The global aspergillosis drugs market is expected to experience steady growth through 2034, with its market value projected to increase from 1.32 billion US dollars in 2025 to 2.44 billion US dollars by 2034. The market is estimated to register a compound annual growth rate of 7.06 percent during the forecast period from 2026 to 2034. This anticipated expansion highlights the future development...

The global Aspergillosis Drugs market is witnessing steady growth, driven by the increasing incidence of Aspergillosis infections, advancements in antifungal drug development, and the rising number of organ transplantation procedures. The Aspergillosis Drugs market was valued at US$ 1.32 billion in 2025 and is expected to reach US$ 2.44 billion by 2034, registering a CAGR of 7.06% during...